News
MALVERN, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for ...
Poster #3 : Advancing buntanetap: comparative pharmacokinetic characterization of the original semi-crystalline with the novel crystalline form in animals and humans.
Lindsey Knight’s fascination with scientific research began at a young age. As a 9-year-old, she participated in a science ...
Sugar.fit's Research Accepted at the American Diabetes Association's 85th Scientific Sessions in Chicago ...
Rising senior Ciara Luttrell wanted to learn about health literacy this summer. So Dr. Lorne Farovitch, ’14, the founder and ...
Every child can develop Leonardo's genius-level thinking through cross-domain connections. Parents can teach these strategies ...
The RSC Nucleic Acids Group invites you to their Forum meeting, which will take place in-person at the RSC's iconic Burlington House in London. This is the NAG’s annual meeting, bringing together the ...
New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...
High school students from across the state have spent the last six weeks out on the water as part of the GenSea Blue Economy Pathways internship. The program wrapped up Thursday evening with a poster ...
Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced an oral presentation ...
I had no idea what it was and then I remember one of the program coordinators at the time gave a presentation about Upward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results